Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give informed consent and take part in the study.
- People who are 18 years of age or older (or the legal age of adulthood in their country, if that is older than 18).
- People who have had documented gastroesophageal reflux disease (acid reflux) for more than 6 months.
- People whose acid reflux has been confirmed by a 24-hour pH monitoring test (a test that measures acid levels in the food pipe), taken after stopping acid-reducing medication for at least 7 days, with results meeting specific thresholds for acid exposure or reflux episodes (confirm with trial site for exact values).
- People who a doctor has assessed as suitable to have a procedure under general anaesthetic using keyhole (laparoscopic) surgery.
Who may not be able to join:
- People who have a hiatal hernia (where part of the stomach pushes up into the chest) larger than 3 centimetres.
- People known to have slow stomach emptying, where no other cause for their acid reflux has been identified.
- People who have previously had weight-loss (bariatric) surgery in which part of the stomach (the fundus) was removed.
- People who are pregnant or breastfeeding.
- People with a known sensitivity or allergy to silicone materials.
- People in whom the surgeon finds something during the procedure that makes it unsuitable to continue with the study, as outlined in the device instructions.
- People who are unable to follow the study requirements, for example due to a significant mental health condition, or who the investigator considers otherwise unsuitable for participation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yves Borbély, Dr. med., Inselspital, Universitätsspital Bern
Phone: +41 78 249 77 28
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary safety endpoint; Primary performance endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.